47444-62-2 Usage
General Description
The chemical 2,5-Oxazolidinedione, 4-[[1-(2,4-dinitrophenyl)-1H-imidazol-4-yl]methyl]-, (4S)- is a compound with the molecular formula C13H10N6O8. It is a derivative of oxazolidinedione and contains a 2,4-dinitrophenyl and an imidazol-4-ylmethyl group. The stereochemistry of the compound is specified as (4S)-, indicating the relative configuration of the chiral center at the 4 position. This chemical may have potential applications in medicinal and pharmaceutical research due to its unique structure and functional groups, which could interact with biological systems in meaningful ways. Further studies and research may be needed to fully understand the properties and potential uses of 2,5-Oxazolidinedione,
4-[[1-(2,4-dinitrophenyl)-1H-imidazol-4-yl]methyl]-, (4S)-.
Check Digit Verification of cas no
The CAS Registry Mumber 47444-62-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,7,4,4 and 4 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 47444-62:
(7*4)+(6*7)+(5*4)+(4*4)+(3*4)+(2*6)+(1*2)=132
132 % 10 = 2
So 47444-62-2 is a valid CAS Registry Number.
47444-62-2Relevant academic research and scientific papers
Li, Zhen,Chen, Qixian,Qi, Yan,Liu, Zhihao,Hao, Tangna,Sun, Xiaoxin,Qiao, Mingxi,Ma, Xiaodong,Xu, Ting,Zhao, Xiuli,Yang, Chunrong,Chen, Dawei
, p. 2595 - 2609 (2018)
A multifunctional nanoparticulate system composed of methoxy poly(ethylene glycol)-poly(l-histidine)-d-α-vitamin E succinate (MPEG-PLH-VES) copolymers for encapsulation of doxorubicin (DOX) was elaborated with the aim of circumventing the multidrug resist
Dendritic polypeptide-based nanocarriers for the delivery of therapeutic agents
-
Page/Page column 15-17, (2018/04/25)
Dendritic polypeptides useful for the delivery of therapeutic agents into cells are disclosed, together with their methods of preparation. These dendritic polypeptides serve as carriers of drugs, siRNA, aptamers and plasmid DNA in the treatment of various